High-dose vitamin C blocks HOCl production by Myeloperoxidase: A potential therapeutic strategy
Open Access
- 18 June 2025
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 776, 152213
Abstract
No abstract availableKeywords
All Related Versions
This publication has 67 references indexed in Scilit:
- Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancerCancer Immunology, Immunotherapy, 2024
- O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological AscorbateCancer Cell, 2017
- Characterization of dehydroascorbate‐mediated modification of glutaredoxin by mass spectrometryJournal of Mass Spectrometry, 2015
- Restoring physiological levels of ascorbate slows tumor growth and moderates HIF‐1 pathway activity in Gulo−/− miceCancer Medicine, 2014
- Dehydroascorbic acid as an anti-cancer agentCancer Letters, 2008
- Oxidation of Clozapine and Ascorbate by MyeloperoxidaseArchives of Biochemistry and Biophysics, 1999
- Ascorbic Acid Oxidation by Hydrogen PeroxideAnalytical Biochemistry, 1998
- Kinetics and Mechanisms of Hypochlorous Acid ReactionsArchives of Biochemistry and Biophysics, 1995
- Unequivocal evidence in support of the nonenzymatic redox coupling between glutathione/glutathione disulfide and ascorbic acid/dehydroascorbic acidBiochimica et Biophysica Acta (BBA) - General Subjects, 1992
- Oxidation of methionine: Effect of ascorbic acid autoxidationFood Chemistry, 1981